We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| C.R. Bard, Inc. (delisted) | NYSE:BCR | NYSE | Ordinary Share |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 331.24 | 0.00 | 01:00:00 |
From May 2019 to May 2024
Johnson & Johnson (JNJ) will, over the next four months, phase out four surgical mesh products used to treat pelvic collapse in women, the Associated Press reported Tuesday.
The Food and Drug Administration has ordered new studies of the products as it has received hundreds of reports of complications related to the implants, according to earlier reports.
Pelvic-mesh products products, also made by companies including Boston Scientific Corp. (BSX) and C.R. Bard Inc. (BCR), are also at the center of lawsuits in New Jersey and West Virginia.
Full story at http://hosted.ap.org/dynamic/stories/U/US_JJ_PELVIC_IMPLANT?SITE=AP&SECTION=HOME&TEMPLATE=DEFAULT
Write to nymonitoring@dowjones.com
1 Year Bard C R Chart |
1 Month Bard C R Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
